|
Sudeep Pharma Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
6607.49 Cr.
|
P/BV
|
8.54
|
Book Value (Rs.)
|
68.49
|
|
52 Week High/Low (Rs.)
|
795/524
|
FV/ML
|
1/1
|
P/E(X)
|
47.64
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.28
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 459.92 | 344.45 |
| Total Income From Operations | 459.92 | 344.45 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 198.37 | 145.25 |
| Increase/Decrease in Stocks | -34.92 | -40.22 |
| Employees Cost | 41.37 | 27.40 |
| Depreciation | 10.92 | 7.76 |
| Other Expenses | 95.79 | 80.85 |
| Total Expenses | 311.54 | 221.04 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 148.38 | 123.41 |
| Other Income | 22.16 | 5.57 |
| P/L Before Interest, Excpt. Items & Tax | 170.54 | 128.98 |
| Interest | 5.16 | 3.99 |
| P/L Before Exceptional Items & Tax | 165.38 | 124.99 |
| P/L Before Tax | 165.38 | 124.99 |
| Tax | 39.63 | 30.45 |
| P/L After Tax from Ordinary Activities | 125.75 | 94.54 |
| Net Profit/Loss For the Period | 125.75 | 94.54 |
| Net P/L After Minority Interest & Share Of Associates | 125.75 | 94.54 |
| | | |
| Equity Share Capital | 11.29 | 9.72 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 11.32 | 8.71 |
| Diluted EPS (Rs.) | 11.32 | 8.71 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 11.32 | 8.71 |
| Diluted EPS (Rs.) | 11.32 | 8.71 |
| | | |
| PBITOE Margin (%) | 32.26 | 35.82 |
| PBTE Margin (%) | 35.95 | 36.28 |
| PBT Margin (%) | 35.95 | 36.28 |
| PAT Margin (%) | 27.34 | 27.44 |
| PAT After MI And SOA Margin (%) | 27.34 | 27.44 |
